Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 06:51:55 +0200Fri, 28 Jun 2024 13:36:00 +0200Human medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aranespHuman medicines European public assessment report (EPAR): Aranesp, darbepoetin alfa, Date of authorisation: 08/06/2001, Revision: 46, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/aranespFri, 28 Jun 2024 13:36:00 +0200Human medicineAranesp-H-C-332-II-0028 : EPAR - Scientific Discussion - Variationhttps://www.ema.europa.eu/system/files/documents/scientific-discussion-variation/wc500026146_en.pdfAranesp-H-C-332-II-0028 : EPAR - Scientific Discussion - Variationhttps://www.ema.europa.eu/system/files/documents/scientific-discussion-variation/wc500026146_en.pdfWed, 14 Jun 2006 02:00:00 +0200Human medicine